IP Verse

Cylodextrin Complexation Methods For Formulating Peptide Proteasome Inhibitors

Patent No. EP2662094 (titled "Cylodextrin Complexation Methods For Formulating Peptide Proteasome Inhibitors") was filed by Onyx Therapeutics on May 8, 2013. The application was issued on Apr 17, 2024.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (6)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
BRAND MURRAY FULLERJan 17, 2025BRAND MURRAY FULLER
HGFJan 17, 2025HGF
RUMIJan 17, 2025TER MEER STEINMEISTER & PARTNER
STADA ARZNEIMITTELJan 17, 2025KERNEBECK
TER MEER STEINMEISTER & PARTNER PATENTANWALTE MBBJan 17, 2025TER MEER STEINMEISTER & PARTNER
FRESENIUS KABI DEUTSCHLANDJan 9, 2025FRESENIUS KABI DEUTSCHLAND

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP2662094

ONYX THERAPEUTICS
Application Number
EP13167148A
Filing Date
May 8, 2013
Status
Granted And Under Opposition
Mar 15, 2024
Publication Date
Apr 17, 2024
External Links
Slate, Register , Google Patents